Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Broadcom Inc (AVGO) vs Centene Corp (CNC) Price & Performance

Broadcom IncTrade
Centene CorpTrade

Price performance (Past 24H)

Key statistics

Broadcom Inc vs Centene Corp — how do they compare? Broadcom Inc trades at $419.97 (market cap $2.01T), while Centene Corp trades at $66.33 (market cap $32.89B). The key difference: Broadcom Inc is far larger — about 61.1× Centene Corp's market cap, and Broadcom Inc pays a 0.62% dividend while Centene Corp pays none. Which is the better fit depends on your goals.

AVGOCNC
Market Cap
$2.01T$32.89B
Sector
TechnologyHealth
52-Week High
$481.57$68.72
52-Week Low
$289.60$26.17
Enterprise Value
$2.05T$21.93B
Dividend Yield
0.62%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Broadcom Inc

Broadcom--the combined entity of Broadcom and Avago--boasts a highly diverse product portfolio across an array of end markets. Avago focused primarily on radio frequency filters and amplifiers used in high-end smartphones, such as the Apple iPhone and Samsung Galaxy devices, in addition to an assortment of solutions for wired infrastructure, enterprise storage, and industrial end markets. Legacy Broadcom targeted networking semiconductors, such as switch and physical layer chips, broadband products (such as television set-top box processors), and connectivity chips that handle standards such as Wi-Fi and Bluetooth. The company has acquired Brocade, CA Technologies, Symantec's enterprise security business, and has a pending deal to acquire VMware to bolster its offerings in software.

Read more on AVGO

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC